Imaging

doi:10.1017/9781108593946.005

Chapter 4 - Imaging

Published online by Cambridge University Press: 21 June 2019

Vyara Valkanova and

Klaus P. Ebmeier

Edited by

Rob Butler and

Cornelius Katona

Show author details

Rob Butler: Affiliation:
Waitemata DHB and North Shore Hospital, Auckland
Cornelius Katona: Affiliation:
Helen Bamber Foundation

Book contents

Get access

Summary

Exactly 21 years have passed since John Besson’s chapter ‘Imaging’ in the previous edition of these seminars. There has been an amazing proliferation of imaging methods, but very little change in the clinical imaging protocols available to the average UK clinician. X-ray computed tomography (CT) still seems to be the mainstay of assessment in the standard psychiatric memory clinic. Magnetic resonance imaging (MRI) tends to be available, but only as a ‘special treat’, often mediated by neurologists, and emission tomography, such as single photon emission computerised tomography (SPECT) and positron emission tomography (PET), is only used in highly specialised cases outside a few academic centres. Apart from generic NHS austerity, ‘health without mental health’, and institutional ageism, what could be the reasons for this?

Information

Type: Chapter
Information: Seminars in Old Age Psychiatry , pp. 41 - 53
DOI: https://doi.org/10.1017/9781108593946.005 [Opens in a new window]
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

McKhann, G. M., Knopman, D. S., Chertkow, H., et al. (2011) ‘The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease’. Alzheimers Dement 7(3): 263–9.Google Scholar

Wardlaw, J., for METACOHORTS Consortium (2016) ‘METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease research’. Alzheimers Dement 12(12): 1235–49.Google Scholar

Suri, S., Valkanova, V., Heise, V., Sexton, C. E., Ebmeier, K. P. (2018) ‘Neuroimaging’. In Oxford Textbook of Old Age Psychiatry, edited by Dening, T., Thomas, A., Stewart, R., Taylor, J.-P.. 3rd ed. Oxford: Oxford University Press.Google Scholar

Ebmeier, K. P., Filippini, N., Mackay, C. E., Suri, S., Valkanova, V. (2016) ‘Functional brain imaging and connectivity in dementia’. In Dementia, edited by Ames, D., Burn, A., O’Brien, J.. 5th ed. London: Taylor & Francis, pp. 107–18.Google Scholar

National Institute for Health and Care Excellence (2018) ‘Dementia: Assessment, management and support for people living with dementia and their carers’. NICE guideline [NG97], June, www.nice.org.uk/guidance/ng97.Google Scholar

Frisoni, G. B., Boccardi, M., Barkhof, F., et al. (2017) ‘Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers’. Lancet Neurol 16(8): 661–76.Google Scholar

Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2009) ‘MRI and CSF biomarkers in normal, MCI, and AD subjects: Diagnostic discrimination and cognitive correlations’. Neurology 73(4): 287–93.Google Scholar

Vemuri, P., Gunter, J. L., Senjem, M. L., et al. (2008) ‘Alzheimer’s disease diagnosis in individual subjects using structural MR images: Validation studies’. Neuroimage 39(3): 1186–97.Google Scholar

Valkanova, V., Ebmeier, K. P. (2014) ‘Neuroimaging in dementia’. Maturitas 79(2): 202–8.Google Scholar

Scheltens, P., Leys, D., Barkhof, F., et al. (1992) ‘Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: Diagnostic value and neuropsychological correlates’. J Neurol Neurosurg Psychiatry 55(10): 967–72.Google Scholar

Herholz, K. (2011) ‘Perfusion SPECT and FDG-PET’. Int Psychogeriatr 23 Suppl 2: S25–31.CrossRef Google Scholar PubMed

Hall, B., Mak, E., Cervenka, S., et al. (2017) ‘In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings’. Ageing Res Rev 36: 50–63.Google Scholar

Donaghy, P., Thomas, A. J., O’Brien, J. T. (2015) ‘Amyloid PET Imaging in Lewy body disorders’. Am J Geriatr Psychiatry 23(1): 23–37.Google Scholar

Mathis, C. A., Lopresti, B. J., Ikonomovic, M. D., Klun, W. E. (2017) ‘Small-molecule PET Tracers for Imaging Proteinopathies’. Semin Nucl Med 47(5): 553–75.Google Scholar

Jack, C. R. Jr., Wiste, H. J., Weigand, S. D., et al. (2013) ‘Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity’. Neurology 81(20): 1732–40.Google Scholar

Prestia, A., Caroli, A., van der Flier, W. M., et al. (2013) ‘Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease’. Neurology 80(11): 1048–56.Google Scholar

Smailagic, N., Vacante, M., Hyde, C., et al. (2015) ‘(1)(8)F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)’. Cochrane Database Syst Rev 1: Cd010632.Google Scholar

Zhang, S., Smailagic, N., Hyde, C., et al. (2014) ‘(11)C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)’. Cochrane Database Syst Rev 7: Cd010386.Google Scholar

Wardlaw, J. M., Smith, E. E., Biessels, G. J., et al. (2013) ‘Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration’. Lancet Neurol 12(8): 822–38.Google Scholar

Perneczky, R., Tene, O., Attems, J., et al. (2016) ‘Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group’. BMC Med 14(1): 162.Google Scholar

Narayanan, L., Murray, A. D. (2016) ‘What can imaging tell us about cognitive impairment and dementia?’ World J Radiol 8(3): 240–54.CrossRef Google Scholar PubMed

Wahlund, L. O., Barkhof, F., Fazekas, F., et al. (2001) ‘A new rating scale for age-related white matter changes applicable to MRI and CT’. Stroke 32(6): 1318–22.Google Scholar

Suri, S., Topiwala, A., Mackay, C. E., et al. (2014) ‘Using structural and diffusion magnetic resonance imaging to differentiate the dementias’. Curr Neurol Neurosci Rep 14(9): 475.Google Scholar

McKeith, I. G., Boeve, B. F., Dickson, D. W., et al. (2017) ‘Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium’. Neurology 89(1): 88–100.CrossRef Google Scholar PubMed

Broski, S. M., Hunt, C. H., Johnson, G. B., et al. (2014) ‘Structural and functional imaging in parkinsonian syndromes’. Radiographics 34(5): 1273–92.CrossRef Google Scholar PubMed

Rascovsky, K., Hodges, J. R., Knopman, D., et al. (2011) ‘Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia’. Brain 134(Pt 9): 2456–77.CrossRef Google Scholar PubMed

Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., et al. (2011) ‘Classification of primary progressive aphasia and its variants’. Neurology 76(11): 1006–14.Google Scholar

Meeter, L. H., Kaat, L. D., Rohrer, J. D., van Swieten, J. C. (2017) ‘Imaging and fluid biomarkers in frontotemporal dementia’. Nat Rev Neurol 13(7): 406–19.Google Scholar

Alexopoulos, G. S. (2006) ‘The vascular depression hypothesis: 10 years later’. Biol Psychiatry 60(12): 1304–5.Google Scholar

Aizenstein, H. J., Baskys, A., Boldrini, M., et al. (2016) ‘Vascular depression consensus report – A critical update’. BMC Med 14(1): 161.Google Scholar

Wen, M. C., Steffens, D. C., Chen, M. K., Zainal, N. H. (2014) ‘Diffusion tensor imaging studies in late-life depression: Systematic review and meta-analysis’. Int J Geriatr Psychiatry 29(12): 1173–84.Google Scholar

Filippini, N., Zsoldos, E., Haapakoski, R., et al. (2014) ‘Study protocol: The Whitehall II imaging sub-study’. BMC Psychiatry 14: 159.Google Scholar

Alfaro-Almagro, F., Jenkinson, M., Bangerter, N. K., et al. (2017) ‘Image processing and quality control for the first 10,000 brain imaging datasets from UK Biobank’. Neuroimage 166: 400–24.Google Scholar

Smith, S. M., Beckmann, C. F., Andersson, J., et al. (2013) ‘Resting-state fMRI in the Human Connectome Project’. Neuroimage 80: 144–68.Google Scholar

Walhovd, K. B., Fjell, A. M., Westerhausen, R., et al. (2017) ‘Healthy minds from 0–100 years: Optimising the use of European brain imaging cohorts (“Lifebrain”)’. Eur Psychiatry 47: 76–87.Google Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future.